SUPN — Supernus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Supernus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	340	461	255	454	309
Net Total Accounts Receivable
Net Total Receivables	149	165	144	142	226
Total Inventory
Prepaid Expenses
Total Current Assets	602	734	493	686	644
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	52.3	44.1	42.5	36	37.2
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,689	1,703	1,278	1,368	1,453
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	315	688	290	292	338
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	873	816	356	332	391
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	816	886	922	1,036	1,062
Total Liabilities & Shareholders' Equity	1,689	1,703	1,278	1,368	1,453
Total Common Shares Outstanding